Aller directement au contenu principal

Rédiger un PREreview

R21/Matrix-M Malaria Vaccine Uptake and Dose Completion Among Rural Niger Delta Children

Publié
Serveur de preprints
Preprints.org
DOI
10.20944/preprints202609.0523.v1

Rationale: The successful deployment of malaria vaccines requires not only achieving initial vaccine uptake but also ensuring completion of the recommended multi-dose schedule. However, evidence on real-world implementation performance and retention patterns of the R21/Matrix-M malaria vaccine in rural African healthcare settings remains limited. Understanding where attrition occurs across the vaccination cascade is essential for designing targeted strategies that maximize vaccine impact. Objective: This study evaluated uptake, retention, geographic variation, and implementation bottlenecks affecting completion of the four-dose R21/Matrix-M malaria vaccine schedule among children aged 5-11 months in rural Niger Delta healthcare facilities. Methods: A retrospective programme evaluation was conducted using aggregated vaccination records from nine primary healthcare facilities. The analysis assessed dose-specific coverage, facility- and community-level disparities, retention across vaccination transitions, and the relative contribution of implementation failure points. Coverage was calculated using the registered eligible catchment population (n = 4,714), while retention and dropout analyses quantified losses throughout the vaccination cascade. Results: Among 4,714 eligible children, 2,487 initiated vaccination, achieving 52.8% Dose 1 coverage. Retention declined to 72.1% after Dose 2 (1,794 children), 57.8% after Dose 3 (1,437 children), and 0.9% after Dose 4 (23 children). Facility-level Dose 1 uptake ranged from 12.8% to 87.4%, whereas no facility exceeded 2.0% booster completion. Geographic disparities were observed, with Oloibiri and Anyama clans demonstrating higher initiation coverage (75.6% and 71.2%, respectively) compared with Abureni (18.3%). The largest implementation failure occurred between Dose 3 and Dose 4, accounting for 1,414 losses (57.4% of post-initiation dropout). Conclusion: R21/Matrix-M vaccine implementation achieved moderate initial reach but experienced severe failure in maintaining children through schedule completion. The dominant programme constraint was inadequate retention rather than vaccine initiation alone. Recommendation: Malaria vaccine programmes should incorporate longitudinal tracking systems, caregiver reminder platforms, community health worker follow-up, and integration with routine immunization services to improve completion rates. These findings show that vaccine availability does not guarantee population protection; sustainable malaria control requires implementation systems that can convert early vaccine access into complete vaccination coverage.

Vous pouvez rédiger un PREreview de R21/Matrix-M Malaria Vaccine Uptake and Dose Completion Among Rural Niger Delta Children. Un PREreview est une évaluation d'un preprint et peut varier de quelques phrases à un rapport détaillé, semblable à un rapport d'évaluation par les pairs organisé par une revue.

Avant de commencer

Nous vous demanderons de vous connecter avec votre identifiant ORCID iD. Si vous n'en avez pas, vous pouvez en créer un.

Qu’est-ce qu’un ORCID iD ?

Un ORCID iD est un identifiant unique qui vous distingue de toute personne ayant le même nom ou nom similaire.

Commencer maintenant